Improved clinical efficacy of melasma with combination therapy of intense pulsed light and tranexamic acid: A retrospective analysis
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
This study aimed to evaluate the efficacy and safety of intense pulsed light (IPL) therapy as a standalone treatment versus IPL therapy combined with tranexamic acid (TA) microneedling for the management of melasma. Clinical data of 29 patients with melasma were reviewed retrospectively. Patients were divided into 2 groups based on their treatment regimens: the IPL group, which received 3 sessions of IPL therapy, and the IPL + TA group, which underwent IPL therapy immediately followed by TA microneedling. Patients were comprehensively analyzed before treatment, as well as one month and 3 months after the final treatment, utilizing the VISIA skin imaging system, Melasma Area and Severity Index (MASI) scoring, patient satisfaction surveys, recurrence evaluations, and assessments of tolerability and adverse reactions. Both groups exhibited notable improvements in VISIA results and MASI scores post-treatment, with no statistically significant differences between the 2 groups. However, the IPL + TA group reported higher patient satisfaction rates and a lower recurrence rate compared to the IPL group. Both treatments were well-tolerated, with no severe adverse reactions reported. Both IPL therapy alone and IPL therapy combined with TA microneedling have demonstrated efficacy and safety in the treatment for melasma. However, the combination therapy may offer greater patient satisfaction and a reduced risk of recurrence.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Improved clinical efficacy of melasma with combination therapy of intense pulsed light and tranexamic acid: A retrospective analysis
- Date Crossref
- 13/03/2026
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
First Affiliated Hospital of Xi'an Jiaotong University Department of Dermatology pays non établi dans la noticeÉtablissement de santé
-
Sun Yat-sen University pays non établi dans la noticeUniversité ou école supérieure
-
Weinan Central Hospital Department of Dermatology pays non établi dans la noticeÉtablissement de santé
-
Xi'an Jiaotong University pays non établi dans la noticeUniversité ou école supérieure
-
Zhongshan School of Medicine pays non établi dans la noticeUniversité ou école supérieure
Department of Dermatology — First Affiliated Hospital of Xi'an Jiaotong University, Sun Yat-sen University et Department of Dermatology — Weinan Central Hospital, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.